NCT05110404

Brief Summary

Recently, HIIT has been recommended by the American diabetes association for type 2 diabetes. The high-volume HIIT has been studied extensively in patients with type 2 diabetes, however, little is known about the effectiveness of low-volume HIIT regarding target glycemic or lipid control in these patients. Therefore, the purpose of this study is to compare between two subtypes of HIIT (i.e. the low-volume HIIT versus the high-volume HIIT) with respect to exercise-induced changes in blood glucose, lipid profile and anthropometry in patients with type 2 diabetes mellitus. Statement of the Problem Is there any difference between the effect of high-volume and the low-volume high intensity interval training on glycemic and lipids control in type 2 diabetes? Purpose of the study: To assess the effect of the high-volume versus the low-volume high intensity interval training on glycemic and blood lipids control in type 2 diabetes. Null Hypothesis: There will be no difference between the effect of the high-volume versus the low-volume high intensity interval training on glycemic and blood lipids control in type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 8, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

December 25, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

4 months

First QC Date

October 21, 2021

Last Update Submit

February 20, 2023

Conditions

Keywords

DM

Outcome Measures

Primary Outcomes (7)

  • body mass index

    change in body mass index

    12 weeks

  • waist circumference

    change in waist circumference

    12 weeks

  • waist/hip ratio

    change in waist/hip ratio

    12 weeks

  • Systolic and diastolic blood pressure

    change in Systolic and diastolic blood pressure

    12 weeks

  • HbA1c

    change in HbA1c

    12 weeks

  • fasting & 2-h post prandial blood glucose

    change in fasting \& 2-h post prandial blood glucose

    12 weeks

  • fasting lipid profile

    change in fasting lipid profile

    12 weeks

Study Arms (3)

Group (A): The high-volume HIIT

ACTIVE COMPARATOR

Exercise group A (n=30): It will include patients that will perform high-volume high-intensity interval training (HIIT), and will receive medical intervention.

Other: The high-volume HIIT

Group (B): The low-volume HIIT

ACTIVE COMPARATOR

Exercise group B (n=30): will receive medical intervention. that will perform the low-volume high-intensity interval training, and will receive medical intervention.

Other: The low-volume HIIT

Group C

NO INTERVENTION

patients will receive medical intervention only.

Interventions

patients will undergo a warm up at 65%-70% of HRpeak for 5 minutes, and then they will walk on a treadmill for 4 intervals of 4 min each at an intensity corresponding to 85%-90% of HRpeak with 3 min active recovery interval interval in between at 65%-75% of HRpeak. Finally, a 3-min cool-down period will be permitted. The speed and the inclination of the treadmill will be adjusted between intervals to ensure that all patients are exercising at the desired target heart rate monitored by Pulse Oximeter.

Group (A): The high-volume HIIT

Each session will start with a 5-minute warm up at 65-70% of peak HR. Then they will walk on a treadmill for 4 intervals of 2 min each at an intensity corresponding to 85%-90% of HRpeak with three intervals of active recovery in between for 2 min at 65%-75% of HRpeak. Finally, a 3-min cool-down period will be permitted.

Group (B): The low-volume HIIT

Eligibility Criteria

Age35 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Type II diabetes mellitus diagnosed by a physician as having HbA 1c of \> 6.5%.
  • An established diagnosis of T2DM for at least 1year and less than 5 years.
  • Women patients.
  • Age between 35 to 45 years old.
  • Systolic Blood pressure less than or equal 130 mmHg.
  • Obese patients (BMI is between 30 and 39.9 kg/m 2 )
  • Patients with HbA 1c of 7-9%.
  • A self-reported sedentary lifestyle.
  • Patients receiving oral hypoglycemic medications described by the physician
  • Patients with hyperlipidemia.

You may not qualify if:

  • Patients with Cardiac diseases.
  • Patients with glaucoma.
  • Patients with diabetic complications (Diabetic foot, retinopathy, nephropathy, and diabetic peripheral neuropathy).
  • Musculoskeletal or neurological limitations to physical exercise.
  • Pregnancy
  • Patients under insulin therapy
  • Patients with poorly controlled DM (HbA1c \> 9%)
  • Bronchial asthma and chronic obstructive pulmonary disease.
  • Smokers.
  • Morbidly obese BMI ≥ 40 kg/m 2
  • Males.
  • \. Systolic Blood pressure more than 130 mmHg. 12. Anemia ( hemoglobin \< 12 g/dL) 13. Osteopenia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy cairo University

Cairo, Egypt

Location

Related Publications (1)

  • Ahmad AM, Mahmoud AM, Serry ZH, Mohamed MM, Abd Elghaffar HA. Effects of low-versus high-volume high-intensity interval training on glycemic control and quality of life in obese women with type 2 diabetes. A randomized controlled trial. J Exerc Sci Fit. 2023 Oct;21(4):395-404. doi: 10.1016/j.jesf.2023.08.003. Epub 2023 Aug 30.

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist holds a master's degree in Physical therapy for Cardiovascular, Respiratory disorders and geriatrics, Faculty of physical therapy, Cairo university.

Study Record Dates

First Submitted

October 21, 2021

First Posted

November 8, 2021

Study Start

December 25, 2021

Primary Completion

April 30, 2022

Study Completion

May 30, 2022

Last Updated

February 22, 2023

Record last verified: 2023-02

Locations